![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 18, 14665-14674, May 4, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the A number of structurally and functionally diverse
membrane proteins are released from the plasma membrane in a process
termed protein ectodomain shedding. Ectodomain shedding may activate or
inactivate a substrate or change its properties, such as converting a
juxtacrine into a paracrine signaling molecule. Here we have characterized the activities involved in protein ectodomain shedding of
the tumor necrosis factor family member TRANCE/OPGL in different cell types. The criteria used to evaluate these activities include (a) cleavage site usage, (b) response to
activators and inhibitors of intracellular signaling pathways, and
(c) sensitivity to tissue inhibitors of metalloproteases
(TIMPs). At least two TRANCE shedding activities emerged, both of which
are distinct from the tumor necrosis factor
Biochemical and Pharmacological Criteria Define Two Shedding
Activities for TRANCE/OPGL That Are Distinct from the Tumor
Necrosis Factor
Convertase*
§¶,
, and
**
Cellular Biochemistry and Biophysics
Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer
Center, New York, New York 10021 and § Tri-Institutional
(Cornell University/Rockefeller University/Sloan-Kettering Cancer
Center) MD-PhD Training Program, New York, New York 10021
convertase. One of the
TRANCE sheddases is induced by the tyrosine phosphatase inhibitor
pervanadate but not by phorbol esters, whereas the other is refractory
to both of these stimuli. Furthermore, the pervanadate-regulated
sheddase activity is sensitive to TIMP-2 but not TIMP-1, which is
consistent with the properties of a membrane type matrix
metalloprotease. This study provides insights into the properties of
different activities involved in protein ectodomain shedding and has
implications for the functional regulation of TRANCE by potentially
more than one protease.
*
This work was supported in part by a grant from Glaxo
Wellcome (to C. P. B.), by National Institutes of Health
Grant RO1 GM58668 (to C. P. B.), by Memorial Sloan-Kettering
Cancer Center Support Grant NCI-P30-CA-08748, by the Samuel and May
Rudin Foundation, and by the DeWitt Wallace Fund.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Johns Hopkins University School of Medicine,
725 North Wolfe St., PCTB Rm. 714, Baltimore, MD 21205.
**
To whom correspondence should be addressed: Cellular
Biochemistry and Biophysics Program, Sloan-Kettering Inst., Memorial Sloan-Kettering Cancer Center, Box 368, 1275 York Ave., New York, NY
10021. Tel.: 212-639-2915; Fax: 212-717-3047; E-mail:
c-blobel@ski.mskcc.org.
This article has been cited by other articles:
![]() |
D. A. Bergin, C. M. Greene, E. E. Sterchi, C. Kenna, P. Geraghty, A. Belaaouaj, C. C. Taggart, S. J. O'Neill, and N. G. McElvaney Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway J. Biol. Chem., November 14, 2008; 283(46): 31736 - 31744. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wilson, K. C. Nannuru, M. Futakuchi, A. Sadanandam, and R. K. Singh Cathepsin G Enhances Mammary Tumor-Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-{kappa}B Ligand Cancer Res., July 15, 2008; 68(14): 5803 - 5811. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bostanci, G. Emingil, B. Afacan, B. Han, T. Ilgenli, G. Atilla, F.J. Hughes, and G.N. Belibasakis Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE) Levels in Periodontal Diseases J. Dent. Res., March 1, 2008; 87(3): 273 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, B. D. Humphreys, and J. V. Bonventre Shedding of the Urinary Biomarker Kidney Injury Molecule-1 (KIM-1) Is Regulated by MAP Kinases and Juxtamembrane Region J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2704 - 2714. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Bonfil, Z. Dong, J. C. Trindade Filho, A. Sabbota, P. Osenkowski, S. Nabha, H. Yamamoto, S. R. Chinni, H. Zhao, S. Mobashery, et al. Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase: A Pivotal Role in Bone Response and Intraosseous Tumor Growth Am. J. Pathol., June 1, 2007; 170(6): 2100 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamichi, N. Udagawa, Y. Kobayashi, M. Nakamura, Y. Yamamoto, T. Yamashita, T. Mizoguchi, M. Sato, M. Mogi, J. M. Penninger, et al. Osteoprotegerin Reduces the Serum Level of Receptor Activator of NF-{kappa}B Ligand Derived from Osteoblasts J. Immunol., January 1, 2007; 178(1): 192 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hikita, I. Yana, H. Wakeyama, M. Nakamura, Y. Kadono, Y. Oshima, K. Nakamura, M. Seiki, and S. Tanaka Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-{kappa}B Ligand J. Biol. Chem., December 1, 2006; 281(48): 36846 - 36855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Plumb, S McQuaid, A K Cross, J Surr, G Haddock, R A. Bunning, and M N Woodroofe Upregulation of ADAM-17 expression in active lesions in multiple sclerosis Multiple Sclerosis, August 1, 2006; 12(4): 375 - 385. [Abstract] [PDF] |
||||
![]() |
A. S. Cowburn, A. Sobolewski, B. J. Reed, J. Deighton, J. Murray, K. A. Cadwallader, J. R. Bradley, and E. R. Chilvers Aminopeptidase N (CD13) Regulates Tumor Necrosis Factor-{alpha}-induced Apoptosis in Human Neutrophils J. Biol. Chem., May 5, 2006; 281(18): 12458 - 12467. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Schneeweis, D. Willard, and M. E. Milla Functional Dissection of Osteoprotegerin and Its Interaction with Receptor Activator of NF-{kappa}B Ligand J. Biol. Chem., December 16, 2005; 280(50): 41155 - 41164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hikita, Y. Kadono, H. Chikuda, A. Fukuda, H. Wakeyama, H. Yasuda, K. Nakamura, H. Oda, T. Miyazaki, and S. Tanaka Identification of an Alternatively Spliced Variant of Ca2+-promoted Ras Inactivator as a Possible Regulator of RANKL Shedding J. Biol. Chem., December 16, 2005; 280(50): 41700 - 41706. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Buckley, F. N. Rouhani, M. Kaler, B. Adamik, F. I. Hawari, and S. J. Levine Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1132 - L1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sundberg, C. K. Thodeti, M. Kveiborg, C. Larsson, P. Parker, R. Albrechtsen, and U. M. Wewer Regulation of ADAM12 Cell-surface Expression by Protein Kinase C {epsilon} J. Biol. Chem., December 3, 2004; 279(49): 51601 - 51611. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, P. Saftig, D. Hartmann, and C. Blobel Evaluation of the Contribution of Different ADAMs to Tumor Necrosis Factor {alpha} (TNF{alpha}) Shedding and of the Function of the TNF{alpha} Ectodomain in Ensuring Selective Stimulated Shedding by the TNF{alpha} Convertase (TACE/ADAM17) J. Biol. Chem., October 8, 2004; 279(41): 42898 - 42906. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thathiah, M. Brayman, N. Dharmaraj, J. J. Julian, E. L. Lagow, and D. D. Carson Tumor Necrosis Factor {alpha} Stimulates MUC1 Synthesis and Ectodomain Release in a Human Uterine Epithelial Cell Line Endocrinology, September 1, 2004; 145(9): 4192 - 4203. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Tam, C. J. Morrison, Y. I. Wu, M. S. Stack, and C. M. Overall Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates PNAS, May 4, 2004; 101(18): 6917 - 6922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zou, F. Zhu, J. Liu, W. Wang, R. Zhang, C. G. Garlisi, Y.-H. Liu, S. Wang, H. Shah, Y. Wan, et al. Catalytic Activity of Human ADAM33 J. Biol. Chem., March 12, 2004; 279(11): 9818 - 9830. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Velasco-Loyden, J. Arribas, and F. Lopez-Casillas The Shedding of Betaglycan Is Regulated by Pervanadate and Mediated by Membrane Type Matrix Metalloprotease-1 J. Biol. Chem., February 27, 2004; 279(9): 7721 - 7733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Weskamp, J. Schlondorff, L. Lum, J. D. Becherer, T.-W. Kim, P. Saftig, D. Hartmann, G. Murphy, and C. P. Blobel Evidence for a Critical Role of the Tumor Necrosis Factor {alpha} Convertase (TACE) in Ectodomain Shedding of the p75 Neurotrophin Receptor (p75NTR) J. Biol. Chem., February 6, 2004; 279(6): 4241 - 4249. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Zhou, G. Weskamp, V. Chesneau, U. Sahin, A. Vortkamp, K. Horiuchi, R. Chiusaroli, R. Hahn, D. Wilkes, P. Fisher, et al. Essential Role for ADAM19 in Cardiovascular Morphogenesis Mol. Cell. Biol., January 1, 2004; 24(1): 96 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhao, L. Gold, H. Dorward, L.-f. Liang, T. Hoodbhoy, E. Boja, H. M. Fales, and J. Dean Mutation of a Conserved Hydrophobic Patch Prevents Incorporation of ZP3 into the Zona Pellucida Surrounding Mouse Eggs Mol. Cell. Biol., December 15, 2003; 23(24): 8982 - 8991. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Walcheck, S. R. Alexander, C. A. St. Hill, and E. Matala ADAM-17-independent shedding of L-selectin J. Leukoc. Biol., September 1, 2003; 74(3): 389 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Borroto, S. Ruiz-Paz, T. V. de la Torre, M. Borrell-Pages, A. Merlos-Suarez, A. Pandiella, C. P. Blobel, J. Baselga, and J. Arribas Impaired Trafficking and Activation of Tumor Necrosis Factor-{alpha}-converting Enzyme in Cell Mutants Defective in Protein Ectodomain Shedding J. Biol. Chem., July 3, 2003; 278(28): 25933 - 25939. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chesneau, J. D. Becherer, Y. Zheng, H. Erdjument-Bromage, P. Tempst, and C. P. Blobel Catalytic Properties of ADAM19 J. Biol. Chem., June 13, 2003; 278(25): 22331 - 22340. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fan, C. W. Turck, and R. Derynck Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-alpha Converting Enzyme and of an Alternatively Translated Polypeptide J. Biol. Chem., May 9, 2003; 278(20): 18617 - 18627. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thathiah, C. P. Blobel, and D. D. Carson Tumor Necrosis Factor-alpha Converting Enzyme/ADAM 17 Mediates MUC1 Shedding J. Biol. Chem., January 24, 2003; 278(5): 3386 - 3394. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Seals and S. A. Courtneidge The ADAMs family of metalloproteases: multidomain proteins with multiple functions Genes & Dev., January 1, 2003; 17(1): 7 - 30. [Full Text] [PDF] |
||||
![]() |
M. Kaup, K. Dassler, C. Weise, and H. Fuchs Shedding of the Transferrin Receptor Is Mediated Constitutively by an Integral Membrane Metalloprotease Sensitive to Tumor Necrosis Factor alpha Protease Inhibitor-2 J. Biol. Chem., October 4, 2002; 277(41): 38494 - 38502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Merlos-Suarez, S. Ruiz-Paz, J. Baselga, and J. Arribas Metalloprotease-dependent Protransforming Growth Factor-alpha Ectodomain Shedding in the Absence of Tumor Necrosis Factor-alpha -converting Enzyme J. Biol. Chem., December 14, 2001; 276(51): 48510 - 48517. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-c. Zhao, M. Shey, M. Farnsworth, and M. O. Dailey Regulation of Membrane Metalloproteolytic Cleavage of L-selectin (CD62L) by the Epidermal Growth Factor Domain J. Biol. Chem., August 10, 2001; 276(33): 30631 - 30640. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vincent, E. Paitel, P. Saftig, Y. Frobert, D. Hartmann, B. De Strooper, J. Grassi, E. Lopez-Perez, and F. Checler The Disintegrins ADAM10 and TACE Contribute to the Constitutive and Phorbol Ester-regulated Normal Cleavage of the Cellular Prion Protein J. Biol. Chem., October 5, 2001; 276(41): 37743 - 37746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |